Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 7;14(1):66.
doi: 10.1186/s13287-023-03287-7.

Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials

Ahmed Lotfy #  1 , Noha M AboQuella #  2 , Hongjun Wang  3   4
Affiliations
Review

Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials

Ahmed Lotfy et al. Stem Cell Res Ther. .

Abstract

Mesenchymal stromal/stem cells (MSCs) are widely utilized in cell therapy because of their robust immunomodulatory and regenerative properties. Their paracrine activity is one of the most important features that contribute to their efficacy. Recently, it has been demonstrated that the production of various factors via extracellular vesicles, especially exosomes, governs the principal efficacy of MSCs after infusion in experimental models. Compared to MSCs themselves, MSC-derived exosomes (MSC-Exos) have provided significant advantages by efficiently decreasing unfavorable adverse effects, such as infusion-related toxicities. MSC-Exos is becoming a promising cell-free therapeutic tool and an increasing number of clinical studies started to assess the therapeutic effect of MSC-Exos in different diseases. In this review, we summarized the ongoing and completed clinical studies using MSC-Exos for immunomodulation, regenerative medicine, gene delivery, and beyond. Additionally, we summarized MSC-Exos production methods utilized in these studies with an emphasis on MSCs source, MSC-Exos isolation methods, characterization, dosage, and route of administration. Lastly, we discussed the current challenges and future directions of exosome utilization in different clinical studies as a novel therapeutic strategy.

Keywords: Clinical trials; Exosomes; Extracellular vesicles; MSC; Mesenchymal stromal/stem cell.

PubMed Disclaimer

Conflict of interest statement

No potential competing interest was disclosed.

Figures

Fig. 1
Fig. 1
Summary of the MSC-Exos cell sources, isolation approaches and utilization in different diseases
Fig. 2
Fig. 2
Summary of the characterization steps for MSC-Exos
See this image and copyright information in PMC

References

    1. Galipeau J, Sensébé L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018;22(6):824–833. doi: 10.1016/j.stem.2018.05.004. - DOI - PMC - PubMed
    1. Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell Transplant. 2016;25(5):829–848. doi: 10.3727/096368915X689622. - DOI - PubMed
    1. Trento C, Bernardo ME, Nagler A, Kuçi S, Bornhäuser M, Köhl U, et al. Manufacturing mesenchymal stromal cells for the treatment of graft-versus-host disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2018;24(11):2365–2370. doi: 10.1016/j.bbmt.2018.07.015. - DOI - PMC - PubMed
    1. Deng K, Lin DL, Hanzlicek B, Balog B, Penn MS, Kiedrowski MJ, et al. Mesenchymal stem cells and their secretome partially restore nerve and urethral function in a dual muscle and nerve injury stress urinary incontinence model. Am J Physiol Renal Physiol. 2015;308(2):F92–F100. doi: 10.1152/ajprenal.00510.2014. - DOI - PMC - PubMed
    1. Wang Z, Wang Y, Wang Z, Gutkind JS, Wang Z, Wang F, et al. Engineered mesenchymal stem cells with enhanced tropism and paracrine secretion of cytokines and growth factors to treat traumatic brain injury. Stem Cells. 2015;33(2):456–467. doi: 10.1002/stem.1878. - DOI - PubMed

Publication types

LinkOut - more resources